Rare diseases
Investigational molecules
Locations
Back to Italy1 011 clinical trials in Arezzo, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis
ItalyStudy on Ravulizumab for Patients with Thrombotic Microangiopathy After Stem Cell Transplant
ItalyStudy on the Effects and Safety of Emicizumab for Infants with Hemophilia A (Ages Birth to 12 Months)
ItalyStudy Comparing Loncastuximab Tesirine and Rituximab with Standard Treatment for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ItalyStudy on GSK4532990 for Adults with Nonalcoholic Steatohepatitis (NASH)
ItalyStudy on Nivolumab and Ipilimumab for Patients with Untreated Unresectable or Metastatic Urothelial Cancer
ItalyStudy of Ravulizumab for Adults with Lupus Nephritis or IgA Nephropathy
ItalyStudy of daily low-dose temozolomide in patients with advanced neuroendocrine tumors (NETs) who are not eligible for standard treatments due to their health condition
ItalyStudy on Vericiguat for Children with Heart Failure from Left Ventricular Systolic Dysfunction
ItalyStudy Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment
ItalyStudy on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB
ItalyStudy on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on bladder cancer treatments, including innovative therapies combining immunotherapy with established treatments. Studies evaluate new approaches for both muscle-invasive and non-muscle invasive disease.
Multiple trials exploring targeted treatments for patients with various stages of disease progression.
Advanced studies examining new therapeutic approaches for metastatic prostate cancer, including novel drug combinations and targeted therapies for specific genetic mutations.
Investigating innovative treatment sequences and combinations to improve patient outcomes.
Cutting-edge research in renal cell carcinoma treatment, exploring immunotherapy combinations and targeted approaches for both early-stage and metastatic disease.
Focus on improving survival rates through novel therapeutic strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
